share_log

There May Be Underlying Issues With The Quality Of AVE Science&TechnologyLTD's (SHSE:688067) Earnings

There May Be Underlying Issues With The Quality Of AVE Science&TechnologyLTD's (SHSE:688067) Earnings

AVE科技有限公司(SHSE:688067)的盈利質量可能存在潛在問題
Simply Wall St ·  09/04 19:04

Unsurprisingly, AVE Science&Technology CO.,LTD's (SHSE:688067) stock price was strong on the back of its healthy earnings report. However, we think that shareholders may be missing some concerning details in the numbers.

毫不奇怪,AVE 科學與技術有限公司,LTD(上海證券交易所代碼:688067)的股價因其健康的收益報告而表現強勁。但是,我們認爲股東們可能遺漏了一些與數字相關的細節。

big
SHSE:688067 Earnings and Revenue History September 4th 2024
SHSE: 688067 2024 年 9 月 4 日的收益和收入歷史記錄

The Impact Of Unusual Items On Profit

不尋常物品對利潤的影響

For anyone who wants to understand AVE Science&TechnologyLTD's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from CN¥4.1m worth of unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. We ran the numbers on most publicly listed companies worldwide, and it's very common for unusual items to be once-off in nature. And, after all, that's exactly what the accounting terminology implies. AVE Science&TechnologyLTD had a rather significant contribution from unusual items relative to its profit to June 2024. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.

對於任何想了解法定數字之外的AVE Science&TechnologyLtd利潤的人來說,值得注意的是,在過去的十二個月中,從價值410萬元人民幣的不尋常物品中獲得了法定利潤。我們不能否認更高的利潤通常會讓我們感到樂觀,但如果利潤是可持續的,我們更願意這樣做。我們統計了全球大多數上市公司的數字,不尋常的物品在自然界中很常見。而且,畢竟,這正是會計術語的含義。截至2024年6月,AVE Science&TechnologyLtd從不尋常的項目中獲得了相當大的利潤。在其他條件相同的情況下,這可能會使法定利潤成爲衡量潛在盈利能力的不良指導。

Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of AVE Science&TechnologyLTD.

注意:我們始終建議投資者檢查資產負債表的實力。點擊此處查看我們對AVE Science&TechnologyLtd的資產負債表分析

Our Take On AVE Science&TechnologyLTD's Profit Performance

我們對AVE科學與技術有限公司利潤表現的看法

As previously mentioned, AVE Science&TechnologyLTD's large boost from unusual items won't be there indefinitely, so its statutory earnings are probably a poor guide to its underlying profitability. As a result, we think it may well be the case that AVE Science&TechnologyLTD's underlying earnings power is lower than its statutory profit. The good news is that, its earnings per share increased by 58% in the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. To help with this, we've discovered 2 warning signs (1 can't be ignored!) that you ought to be aware of before buying any shares in AVE Science&TechnologyLTD.

如前所述,AVE Science&TechnologyLtd從不尋常項目中獲得的巨大提振不會無限期地存在,因此其法定收益可能無法很好地指導其潛在盈利能力。因此,我們認爲AVE Science&TechnologyLtd的基礎盈利能力很可能低於其法定利潤。好消息是,其每股收益在去年增長了58%。本文的目標是評估我們在多大程度上可以依靠法定收益來反映公司的潛力,但還有很多需要考慮的地方。有鑑於此,如果你想對公司進行更多分析,了解所涉及的風險至關重要。爲了幫助解決這個問題,我們發現了 2 個警告信號(1 個不容忽視!)在購買AVE Science&TechnologyLtd的任何股票之前,你應該注意這一點

Today we've zoomed in on a single data point to better understand the nature of AVE Science&TechnologyLTD's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

今天,我們放大了單一數據點,以更好地了解AVE Science&TechnologyLtd利潤的性質。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。有些人認爲高股本回報率是優質業務的好兆頭。雖然可能需要你進行一些研究,但你可能會發現這份免費收集的擁有高股本回報率的公司,或者這份擁有大量內幕持股的股票清單很有用。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論